Stay updated on Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The Publications section now indicates that publications are automatically filled from PubMed and may not be about the study, and the Revision version has been updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:45.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removal of the government funding operating status notice from the page. The notice previously informed users about potential delays and directed to cc.nih.gov and opm.gov for updates.
    Difference
    0.2%
    Check dated 2025-11-18T07:23:38.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Changes are limited to minor UI/layout tweaks and an updated last-updated timestamp; no core study information was altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-27T21:01:15.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic on Prostate cancer, reducing genetic health topic coverage.
    Difference
    0.1%
    Check dated 2025-10-13T11:57:23.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    - Updated page revision from v3.1.0 to v3.2.0 and added a new MedlinePlus Genetics topic: Prostate cancer. - Added a visibility note about government funding impacting operations and where to find status updates.
    Difference
    2%
    Check dated 2025-10-06T07:53:41.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a new version release.
    Difference
    0.0%
    Check dated 2025-09-29T04:14:27.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab vs. Cabazitaxel in Prostate Cancer Clinical Trial page.